Where does St. Jude Medical Luxembourg Holdings SMI S.A.R.L. (“SJM LUX SMI”) rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), St. Jude Medical Luxembourg Holdings SMI S.A.R.L. (“SJM LUX SMI”) ranks #23,458 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Is St. Jude Medical Luxembourg Holdings SMI S.A.R.L. (“SJM LUX SMI”)'s patent grant rate increasing or decreasing?

St. Jude Medical Luxembourg Holdings SMI S.A.R.L. (“SJM LUX SMI”)'s recent grant velocity is -91% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for St. Jude Medical Luxembourg Holdings SMI S.A.R.L. (“SJM LUX SMI”)'s patents?

St. Jude Medical Luxembourg Holdings SMI S.A.R.L. (“SJM LUX SMI”)'s patents average 14.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

St. Jude Medical Luxembourg Holdings SMI S.A.R.L. (“SJM LUX SMI”)

Q: How is the St. Jude Medical Luxembourg Holdings SMI S.A.R.L. (“SJM LUX SMI”) patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 12 granted patents across 6 technology areas, recorded in grant years 2016–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, St. ranks #23,458 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 6 technology areas.

#23,458
of 49,997 US assignees by volume: 43rd percentile
by Innovation Score (33.0/100): 14.8
avg claims per patent: -91%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23458 · Foreign Corporation #23,458 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #23,458/49,997
PHOTO-FINISH Spinal USA
CPC-NARROW A61N · 6 areas
INNOV-THIN 33.0/100
CLAIMS-RICH 14.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -91% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Spinal USA, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How St.’s 33.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (27%) Velocity 6.7 pts (20%) Breadth 8.7 pts (26%) Claim depth 8.9 pts (27%)

Qualcomm Incorporated · highest

85
St Jude Medical… · this assignee

33
3D Lighting… · lowest

7

What this shows St.'s Innovation Score is 33.0/100 (43rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for St.?

Each dot is one of St.’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). St.’s own 14.8 claims/patent is at or below the 15.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

St. vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where St.'s grants concentrate

St. Jude Medical Luxembourg Holdings SMI S.A.R.L. (“SJM LUX SMI”) is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2016 (5 grants) versus a trough of 1 in 2017. By volume, St. sits between Spinal USA, Inc. and Stealthpath, Inc..

St.'s three-year grant acceleration

St. Jude Medical Luxembourg Holdings SMI S.A.R.L. (“SJM LUX SMI”) shows 1 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Spinal USA

12
Spray Moret

12
Spyglass Pharma

12
Sstatzz Oy

12
Starleaf

12
Starlinger & Gese…

12
States Title

12
Stealthpath

12
St Jude Medical L… ◀

12

What this shows St. holds 12 patents at rank #23,467, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near St

By rank, the assignees closest to #23,467 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in St's primary technology class.

St.'s Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 43rd percentile higher than 43% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

St. Jude Medical Luxembourg Holdings SMI S.A.R.L. (“SJM LUX SMI”) patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	5	41.7%
2017	1	8.3%
2018	4	33.3%
2019	1	8.3%
2022	1	8.3%

Which technologies does St. Jude Medical Luxembourg Holdings SMI S.A.R.L. (“SJM LUX SMI”) patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 12

H04B - Transmission 2

H02J - Circuit Arrangements OR Systems FOR Supplying OR Distributing Electric POWER; Systems FOR Storing Electric Energy 2

A61B - DIAGNOSIS; SURGERY; Identification 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

H05K - Printed CIRCUITS; Casings OR Constructional Details OF Electric APPARATUS; Manufacture OF Assemblages OF Electrical Components 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

St. Jude Medical Luxembourg Holdings SMI S.A.R.L. (“SJM LUX SMI”)'s patent record in context - here's where to go next.

St. Jude Medical Luxembourg Holdings SMI S.A.R.L. (“SJM LUX SMI”)'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 100% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #23,458 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare St. Jude Medical Luxembourg Holdings SMI S.A.R.L. (“SJM LUX SMI”) against Spinal USA, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.